Hematology
15
4
4
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
7%
1 trials in Phase 3/4
29%
2 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (15)
Effects of Donor-recipient Sex-matched Blood Transfusion on Patient Outcomes
Goal Attainment Scale in Transplantation
Correlation Between Ultrasound-assessed Quadriceps Muscle Mass and Baseline Whole-body Densitometry Muscle Index in the Post-cancer Population (JUMP Research II)
A Multicenter Observational Study to Understand the Clinical Characteristics, Treatment Patterns and Access to Novel Therapies of Patients With Diffuse Large B-Cell Lymphoma in the MEA Region
The Right Amount of Purge Useful for Blood Sampling on PiccLine (PiccLine)
Increase Understanding and Safety of Treatment
Onco-haematology Vigilance Card
Analytical and Clinical Performance Testing Plan
Performance Evaluation Study
Red Blood Cell Transfusion in the Ambulatory Setting: Impact on Home Functional Status
Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS)
AMG 319 Lymphoid Malignancy FIH
Naproxen Sodium/ASA Platelet Study
Determination of Voriconazole Levels in Saliva - Validation in Specific Subsets of Patients
Pegfilgrastim PBPC Mobilization Study